IDEXX LABORATORIES INC /DE Capital Expenditures Incurred but Not yet Paid
IDEXX LABORATORIES INC /DE (IDXX) reported Capital Expenditures Incurred but Not yet Paid of $9.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $1.45M.
- IDEXX LABORATORIES INC /DE capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $8.27M, a 22.69% decline year-over-year.
- IDEXX LABORATORIES INC /DE capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $8.78M, a 89.61% increase year-over-year.
- IDEXX LABORATORIES INC /DE capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$1.68M, a 180.75% decline year-over-year.
- IDEXX LABORATORIES INC /DE capital expenditures incurred but not yet paid for fiscal 2025 was $15.56M, a 3.48% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE capital expenditures incurred but not yet paid for fiscal 2024 was $15.04M, a 24.67% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE capital expenditures incurred but not yet paid for fiscal 2023 was $12.06M, a 34.22% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE capital expenditures incurred but not yet paid for fiscal 2022 was $18.33M, a 5.13% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $9.72M 10-Q · filed 2026-08-04 | $18.50M derived: sum of 3 quarters · filed 2026-08-04 | $16.82M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $8.27M 10-Q · filed 2026-05-05 | $17.05M derived: sum of 2 quarters · filed 2026-05-05 | $15.37M derived: sum of 3 quarters · filed 2026-05-05 | $13.13M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $7.10M derived: sum of 2 quarters · filed 2026-02-20 | $4.86M derived: sum of 3 quarters · filed 2026-08-04 | $15.56M 10-K · filed 2026-02-20 | |
| 2025-09-30 | -$1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$3.92M derived: sum of 2 quarters · filed 2026-08-04 | $6.78M 10-Q · filed 2025-11-03 | $11.41M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.46M 10-Q · filed 2026-08-04 | $13.09M derived: sum of 3 quarters · filed 2026-08-04 | $15.17M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $10.70M 10-Q · filed 2026-05-05 | $15.33M derived: sum of 2 quarters · filed 2026-05-05 | $17.42M derived: sum of 3 quarters · filed 2026-05-05 | $10.56M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $4.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $6.71M derived: sum of 2 quarters · filed 2026-02-20 | -$146.00K derived: sum of 3 quarters · filed 2026-02-20 | $15.04M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$4.78M derived: sum of 2 quarters · filed 2025-11-03 | $10.40M 10-Q · filed 2025-11-03 | $11.14M derived: sum of 4 quarters · filed 2026-02-20 | |
| 2024-06-30 | -$6.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $8.32M 10-Q · filed 2025-08-04 | $9.05M derived: sum of 3 quarters · filed 2026-02-20 | $4.93M derived: sum of 4 quarters · filed 2026-02-20 | |
| 2024-03-31 | $15.18M 10-Q · filed 2025-05-01 | $15.91M derived: sum of 2 quarters · filed 2026-02-20 | $11.79M derived: sum of 3 quarters · filed 2026-02-20 | $14.79M derived: sum of 4 quarters · filed 2026-02-20 | |
| 2023-12-31 | $733.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$3.39M derived: sum of 2 quarters · filed 2026-02-20 | -$392.00K derived: sum of 3 quarters · filed 2026-02-20 | $12.06M 10-K · filed 2026-02-20 | |
| 2023-09-30 | -$4.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$1.13M derived: sum of 2 quarters · filed 2024-10-31 | $11.33M 10-Q · filed 2024-10-31 | $10.00M derived: sum of 4 quarters · filed 2025-02-21 | |
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $15.45M 10-Q · filed 2024-08-06 | $14.12M derived: sum of 3 quarters · filed 2025-02-21 | $23.44M derived: sum of 4 quarters · filed 2025-02-21 | |
| 2023-03-31 | $12.45M 10-Q · filed 2024-05-01 | $11.13M derived: sum of 2 quarters · filed 2025-02-21 | $20.45M derived: sum of 3 quarters · filed 2025-02-21 | $19.77M derived: sum of 4 quarters · filed 2025-02-21 | |
| 2022-12-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $7.99M derived: sum of 2 quarters · filed 2025-02-21 | $7.32M derived: sum of 3 quarters · filed 2025-02-21 | $18.33M 10-K · filed 2025-02-21 | |
| 2022-09-30 | $9.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $8.64M derived: sum of 2 quarters · filed 2023-11-01 | $19.66M 10-Q · filed 2023-11-01 | $24.25M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | -$676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $10.34M 10-Q · filed 2023-08-01 | $14.93M derived: sum of 3 quarters · filed 2024-02-22 | $19.99M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | $11.02M 10-Q · filed 2023-05-02 | $15.61M derived: sum of 2 quarters · filed 2024-02-22 | $20.67M derived: sum of 3 quarters · filed 2024-02-22 | $23.75M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $9.65M derived: sum of 2 quarters · filed 2024-02-22 | $12.73M derived: sum of 3 quarters · filed 2024-02-22 | $19.33M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $8.14M derived: sum of 2 quarters · filed 2022-11-01 | $14.73M 10-Q · filed 2022-11-01 | $20.37M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $9.68M 10-Q · filed 2022-08-02 | $15.31M derived: sum of 3 quarters · filed 2023-02-16 | $10.35M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-03-31 | $6.59M 10-Q · filed 2022-05-04 | $12.23M derived: sum of 2 quarters · filed 2023-02-16 | $7.26M derived: sum of 3 quarters · filed 2023-02-16 | $5.81M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2020-12-31 | $5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $673.00K derived: sum of 2 quarters · filed 2023-02-16 | -$780.00K derived: sum of 3 quarters · filed 2023-02-16 | $13.34M 10-K · filed 2023-02-16 | |
| 2020-09-30 | -$4.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$6.42M derived: sum of 2 quarters · filed 2021-11-02 | $7.71M 10-Q · filed 2021-11-02 | $13.20M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $12.67M 10-Q · filed 2021-07-30 | $18.16M derived: sum of 3 quarters · filed 2022-02-16 | $25.73M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-31 | $14.12M 10-Q · filed 2021-05-04 | $19.61M derived: sum of 2 quarters · filed 2022-02-16 | $27.18M derived: sum of 3 quarters · filed 2022-02-16 | $29.80M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $13.05M derived: sum of 2 quarters · filed 2022-02-16 | $15.68M derived: sum of 3 quarters · filed 2022-02-16 | $24.69M 10-K · filed 2022-02-16 | |
| 2019-09-30 | $7.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $10.19M derived: sum of 2 quarters · filed 2020-10-29 | $19.20M 10-Q · filed 2020-10-29 | $26.85M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-06-30 | $2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $11.63M 10-Q · filed 2020-07-31 | $19.29M derived: sum of 3 quarters · filed 2021-02-12 | $20.11M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-03-31 | $9.01M 10-Q · filed 2020-04-30 | $16.66M derived: sum of 2 quarters · filed 2021-02-12 | $17.48M derived: sum of 3 quarters · filed 2021-02-12 | ||
| 2018-12-31 | $7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $8.47M derived: sum of 2 quarters · filed 2021-02-12 | $17.89M 10-K · filed 2021-02-12 | ||
| 2018-09-30 | $820.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $10.24M 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | $9.42M 10-Q · filed 2019-08-01 | ||||
| 2017-12-31 | $11.74M 10-K · filed 2020-02-14 | ||||
| 2016-12-31 | $10.60M 10-K · filed 2019-02-15 | ||||
| 2015-12-31 | $8.53M 10-K · filed 2018-02-16 | $8.50M 10-K · filed 2016-02-17 | |||
| 2014-12-31 | $6.51M 10-K · filed 2017-02-17 | $6.50M 10-K · filed 2016-02-17 | |||
| 2013-12-31 | $2.20M 10-K · filed 2016-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |